Ahemolytic PNH (white cell PNH): Clinical features and implications of a distinct phenotype of paroxysmal nocturnal haemoglobinuria
Br J Haematol
.
2024 May;204(5):2121-2124.
doi: 10.1111/bjh.19395.
Epub 2024 Mar 12.
Authors
Zehra Tombul
1
,
Waled Bahaj
2
,
Merve Ozturk
1
,
Bhavisha Patel
3
,
Ahmet Toprak
1
,
Ibrahim Ibrahim
1
,
Weina Chen
4
,
Franklin Fuda
4
,
Olisaemeka D Ogbue
2
,
Carmelo Gurnari
2
5
,
Charles Parker
6
,
Neal S Young
3
,
Jaroslaw P Maciejewski
2
,
Munevver Duran
1
,
Taha Bat
1
Affiliations
1
Division of Hematology-Oncology, UT Southwestern Medical Center, Dallas, Texas, USA.
2
Translational Hematology and Oncology Research, Cleveland Clinic, Cleveland, Ohio, USA.
3
National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA.
4
Department of Pathology, UT Southwestern Medical Center, Dallas, Texas, USA.
5
Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy.
6
Division of Hematology and Hematologic Malignancies, Department of Medicine, University of Utah School of Medicine, Salt Lake City, Utah, USA.
PMID:
38471793
DOI:
10.1111/bjh.19395
No abstract available
Publication types
Letter
Case Reports
MeSH terms
Adult
Aged
Female
Hemoglobinuria, Paroxysmal* / diagnosis
Hemoglobinuria, Paroxysmal* / pathology
Humans
Male
Middle Aged
Phenotype*
Grants and funding
R35HL135795/HL/NHLBI NIH HHS/United States
R35HL135795/HL/NHLBI NIH HHS/United States